{"title":"Making AAVs the Go-To for Making Gene Therapies Go","authors":"MaryAnn Labant","doi":"10.1089/gen.43.10.19","DOIUrl":"https://doi.org/10.1089/gen.43.10.19","url":null,"abstract":"Genetic Engineering & Biotechnology NewsVol. 43, No. 10 Drug DiscoveryMaking AAVs the Go-To for Making Gene Therapies GoIf adeno-associated viruses are to deliver more gene therapies, they will need to address issues such as load capacity, targetability, immunogenicity, and scalabilityMaryAnn LabantMaryAnn LabantSearch for more papers by this authorPublished Online:13 Oct 2023https://doi.org/10.1089/gen.43.10.19AboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetails Volume 43Issue 10Oct 2023 Information© 2023 by GEN PublishingTo cite this article:MaryAnn Labant.Making AAVs the Go-To for Making Gene Therapies Go.Genetic Engineering & Biotechnology News.Oct 2023.46-48, 50, 52.http://doi.org/10.1089/gen.43.10.19Published in Volume: 43 Issue 10: October 13, 2023PDF download","PeriodicalId":50425,"journal":{"name":"Genetic Engineering & Biotechnology News","volume":"168 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135707241","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0